Author | Urinary diversion type (ORC) (% of total cases) | Urinary diversion type (RARC) (% of total cases) | Total cost (ORC) | Total cost (RARC) | Cost advantage for RARC |
---|---|---|---|---|---|
Bansal [13] | Ileal conduit (100%), Orthotopic neobladder (0%), Other (0%) | Ileal conduit (91.4%), Orthotopic neobladder (7.7%), Other (0.9%) | $13,512 | $16,060 | -$2548 |
Bochner [23]a | Ileal conduit (45%) | Ileal conduit (40%) | $16,648 | $18,388 | -$1740 |
Orthotopic neobladder (55%) | Orthotopic neobladder (55%) | $15,311 | $19,231 | -$3920 | |
Martin [21] | Ileal conduit (100%) | Ileal conduit (100%) | N.A. (for institutional reason) | ||
Lee [22] b | Ileal conduit (50%) | Ileal conduit (57%) | $25,505 | $20,659 | $4846 |
Continent cutaneous (22%) | Continent cutaneous (12%) | $22,697 | $22,102 | $595 | |
Orthotopic neobladder (28%) | Orthotopic neobladder (31%) | $20,719 | $22,695 | -$1976 | |
Smith [11] | N.A. | N.A. | $16248c | $14608c | $1640 |
Yu [26]b | Ileal conduit (76.4%) Other (23.4%) | Ileal conduit (75.7%) Other (24.3%) | $28100d | $34303d | -$6203 |
Leow [24] | Ileal conduit (93.9%), Continent (6.1%) | Ileal conduit (91.5%), Orthotopic Continent (8.5%) | $26679d | $30974d | -$4295 |
Hu [25] | Incontinent (81.3%) Continent (4.1%)e | Incontinent (80.5%) Continent (5.0%)e | $32521d | $36121d | -$3600 |
Monn [27] | N.A. | N.A. | $25098d | $30272d | -$5174 |